Global and China RNA-based Biopharmaceuticals Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the RNA-based Biopharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Silence Therapeutics

    • Pfizer

    • Sanofi-Aventis

    • Roche

    • Arrowhead Pharmaceuticals

    • RXi

    • Quark

    • Senesco

    • Calimmune Inc

    • Tekmira

    • Alnylam Pharmaceuticals

    • Gradalis

    • Benitec Biopharma

    • Abbott Laboratories

    • Dicerna

    • Silenseed

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Therapeutics

    • Vaccines

    Application:

    • Cancer

    • Diabetes

    • Tuberculosis

    • Cardiovascular Diseases

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 RNA-based Biopharmaceuticals Industry Overview

      • 1.1.1 RNA-based Biopharmaceuticals Market Scope and Market Segments

      • 1.1.2 RNA-based Biopharmaceuticals Industry Characteristics

      • 1.1.3 Global and China RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China RNA-based Biopharmaceuticals Production Value and Growth Rate (2017-2028)

    • 1.2 Global RNA-based Biopharmaceuticals Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Therapeutics

      • 1.2.2 Vaccines

    • 1.3 Global RNA-based Biopharmaceuticals Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cancer

      • 1.3.2 Diabetes

      • 1.3.3 Tuberculosis

      • 1.3.4 Cardiovascular Diseases

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global RNA-based Biopharmaceuticals Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 RNA-based Biopharmaceuticals Industry Porter's Five Forces Model Analysis

      • 2.2.3 RNA-based Biopharmaceuticals Industry PEST Analysis

    • 2.3 RNA-based Biopharmaceuticals Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 RNA-based Biopharmaceuticals Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on RNA-based Biopharmaceuticals Industry

    Chapter 3 Global and China RNA-based Biopharmaceuticals Market, by Manufacturer

    • 3.1 Global and China RNA-based Biopharmaceuticals Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China RNA-based Biopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China RNA-based Biopharmaceuticals Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China RNA-based Biopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China RNA-based Biopharmaceuticals Market Top 3 Players

    Chapter 4 Global and China RNA-based Biopharmaceuticals Market, by Type (2017-2028)

    • 4.1 RNA-based Biopharmaceuticals Market Trend, by Type

    • 4.2 Global RNA-based Biopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global RNA-based Biopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global RNA-based Biopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global RNA-based Biopharmaceuticals Price Trend, by Type (2017-2028)

    • 4.3 China RNA-based Biopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China RNA-based Biopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China RNA-based Biopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China RNA-based Biopharmaceuticals Price Trend, by Type (2017-2028)

    Chapter 5 Global and China RNA-based Biopharmaceuticals Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global RNA-based Biopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global RNA-based Biopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global RNA-based Biopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China RNA-based Biopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China RNA-based Biopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China RNA-based Biopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global RNA-based Biopharmaceuticals Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America RNA-based Biopharmaceuticals Market Analysis

    • 7.1 North America RNA-based Biopharmaceuticals Market, by Type

    • 7.2 North America RNA-based Biopharmaceuticals Market, by Application

    • 7.3 North America RNA-based Biopharmaceuticals Market Analysis and Forecast, by Country

      • 7.3.1 United States RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe RNA-based Biopharmaceuticals Market Analysis

    • 8.1 Europe RNA-based Biopharmaceuticals Market, by Type

    • 8.2 Europe RNA-based Biopharmaceuticals Market, by Application

    • 8.3 Europe RNA-based Biopharmaceuticals Market Analysis and Forecast, by Country

      • 8.3.1 Germany RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC RNA-based Biopharmaceuticals Market Analysis

    • 9.1 APAC RNA-based Biopharmaceuticals Market, by Type

    • 9.2 APAC RNA-based Biopharmaceuticals Market, by Application

    • 9.3 APAC RNA-based Biopharmaceuticals Market Analysis and Forecast, by Country

      • 9.3.1 China RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Market Analysis

    • 10.1 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Market, by Type

    • 10.2 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Market, by Application

    • 10.3 Latin America, Middle East and Africa RNA-based Biopharmaceuticals Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina RNA-based Biopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China RNA-based Biopharmaceuticals Company Profiles

      • 11.1 Silence Therapeutics

        • 11.1.1 Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Silence Therapeutics RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.1.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer

        • 11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.2.3 Pfizer RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sanofi-Aventis

        • 11.3.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sanofi-Aventis RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Roche

        • 11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Roche RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.4.3 Roche RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Arrowhead Pharmaceuticals

        • 11.5.1 Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 RXi

        • 11.6.1 RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 RXi RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.6.3 RXi RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Quark

        • 11.7.1 Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Quark RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.7.3 Quark RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Senesco

        • 11.8.1 Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Senesco RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.8.3 Senesco RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Calimmune Inc

        • 11.9.1 Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Calimmune Inc RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.9.3 Calimmune Inc RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Tekmira

        • 11.10.1 Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Tekmira RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.10.3 Tekmira RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Alnylam Pharmaceuticals

        • 11.11.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.11.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Gradalis

        • 11.12.1 Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Gradalis RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.12.3 Gradalis RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Benitec Biopharma

        • 11.13.1 Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Benitec Biopharma RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.13.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Abbott Laboratories

        • 11.14.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Abbott Laboratories RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.14.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Dicerna

        • 11.15.1 Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Dicerna RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.15.3 Dicerna RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Silenseed

        • 11.16.1 Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Silenseed RNA-based Biopharmaceuticals Product Profiles, Application and Specification

        • 11.16.3 Silenseed RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 RNA-based Biopharmaceuticals Industry Investment Prospect and Risk Assessment

    • 12.1 RNA-based Biopharmaceuticals Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 RNA-based Biopharmaceuticals Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Therapeutics (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Vaccines (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Diabetes (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Tuberculosis (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Market Size and Growth Rate of Others (2017-2028)

    • Figure North America RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China RNA-based Biopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China RNA-based Biopharmaceuticals Sales Value, by Manufacturer (2021&2022)

    • Table Global and China RNA-based Biopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • Figure Global and China RNA-based Biopharmaceuticals Market Share, by Manufacturer in 2021

    • Figure Global and China RNA-based Biopharmaceuticals Market Share, by Manufacturer in 2022

    • Table Global RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Value, by Type (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Price Trend, by Type (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Value, by Type (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Price Trend, by Type (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Value, by Application (2017-2028)

    • Table Global RNA-based Biopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure Global RNA-based Biopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Value, by Application (2017-2028)

    • Table China RNA-based Biopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure North America RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Europe RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure APAC RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa RNA-based Biopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Table North America RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table North America RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure North America RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table North America RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table North America RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure North America RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure United States RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure United States RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Canada RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Canada RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Mexico RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Europe RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Europe RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Europe RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Europe RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Europe RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Europe RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Germany RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Germany RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure UK RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure UK RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure France RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure France RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Italy RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Italy RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Spain RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Spain RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Belgium RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Poland RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Poland RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Russia RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Russia RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Turkey RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table APAC RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table APAC RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure APAC RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table APAC RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table APAC RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure APAC RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Japan RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Japan RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure India RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure India RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Korea RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa RNA-based Biopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Brazil RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Africa RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Argentina RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina RNA-based Biopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silence Therapeutics Product Profiles, Application and Specification

    • Table Silence Therapeutics RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi-Aventis Product Profiles, Application and Specification

    • Table Sanofi-Aventis RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arrowhead Pharmaceuticals Product Profiles, Application and Specification

    • Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RXi Product Profiles, Application and Specification

    • Table RXi RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quark Product Profiles, Application and Specification

    • Table Quark RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Senesco Product Profiles, Application and Specification

    • Table Senesco RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Calimmune Inc Product Profiles, Application and Specification

    • Table Calimmune Inc RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tekmira Product Profiles, Application and Specification

    • Table Tekmira RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gradalis Product Profiles, Application and Specification

    • Table Gradalis RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Benitec Biopharma Product Profiles, Application and Specification

    • Table Benitec Biopharma RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dicerna Product Profiles, Application and Specification

    • Table Dicerna RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silenseed Product Profiles, Application and Specification

    • Table Silenseed RNA-based Biopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.